The study was presented at the annual scientific meeting of the 104 American Urological Association (AUA), and showed that it was well tolerated injection of muscle-derived cells and a significant improvement in symptoms.
The researchers conducted a study of two stages on the efficacy and safety of muscle-derived cell transplantation.Articles Sources by Venus Factor Review
In the early stages of the study, which is still ongoing, has received 29 women (average age of 49.5 percent), which stress incontinence symptoms do not improve within a year of standard therapy, with the help of cystoscope injected cells urethra.
In the three-month follow-up appointment, participants could elect a second injection of the same dose. Follow-up occurred at one month, three, six and 12 after the last injection.
The clinical results were evaluated with the test platform weight, voiding diary and verification of the quality of life questionnaires.
In the first phase, double-blind, and had 20 patients were randomized into five groups to receive one or two or four or eight or 16 × 106 AMDCs. In the second stage, and one is blind, and nine patients randomly assigned to three groups to receive 32.64, or 128 × 106 AMDCs.
No comments:
Post a Comment